MET vs PGEN · P/E 13, rev $38.23B vs rev $78.2M
MetLife Inc (MET) versus Precigen Inc (PGEN) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Latest reported PGEN revenue for 2026-06-30 was $78.2M. Net income was $12.1M. PGEN currently screens at market cap $419.2M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. PGEN currently screens at market cap $419.2M.
Not investment advice. Open the MET and PGEN stock pages for the full models.
Not investment advice.